Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines

Investigational drugs in recent clinical trials for treatment-resistant depression

(2017) Ricardo P. Garay et al.   Expert Review of Neurotherapeutics

Naming for Psychotropic Drugs: Dilemma and Challenge

(2017) Hiroyuki Uchida et al.   PHARMACOPSYCHIATRY

Investigational drugs in recent clinical trials for treatment-resistant depression

(2017) Ricardo P. Garay et al.   Expert Review of Neurotherapeutics

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study

(2016) Trisha Suppes et al.   AMERICAN JOURNAL OF PSYCHIATRY

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder

(2016) Ewgeni Jakubovski et al.   AMERICAN JOURNAL OF PSYCHIATRY

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

(2016) Sidney H. Kennedy et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials

(2016) Kim S. J. Lao et al.   CNS DRUGS

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants

(2016) Suresh Durgam et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pharmacotherapy in Psychiatric Disorders of Children: Current Evidence and Trends

(2016) M. Kölch et al.   PHARMACOPSYCHIATRY

Pediatric Psychopharmacology

(2016) B. Vitiello   PHARMACOPSYCHIATRY

Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression

(2016) H. Eyre et al.   PHARMACOPSYCHIATRY

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

(2016) T. Kishimoto et al.   PSYCHOLOGICAL MEDICINE

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

(2015) Gin S Malhi et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis

(2015) Xinyu Zhou et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

(2015) Anthony Cleare et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder

(2015) G I Papakostas et al.   MOLECULAR PSYCHIATRY

Treating Depression with Botulinum Toxin: A Pooled Analysis of Randomized Controlled Trials

(2015) M. Magid et al.   PHARMACOPSYCHIATRY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015

(2015) Michael Bauer et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

(2013) Michael Bauer et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes

(2013) Glen I. Spielmans et al.   PLOS MEDICINE

No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy

(2009) T. Bschor et al.   ACTA PSYCHIATRICA SCANDINAVICA